Numinus Appoints New Bioscience Advisors to Advance IP Development
Advisors lead their fields in patent law, nutraceuticals & ethnobotany VANCOUVER, BC, Feb. 1, 2022 – Numinus’s Wellness Inc. (TSX:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental healthcare company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce…